Andrea Corcoran

CIK: 0001296996

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AVIR

Atea Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

AVIR
Atea Pharmaceuticals, Inc.
Mar 11, 2026
Exercise(M)
Direct
60K shares at avg. $1.24$74K
AVIR
Atea Pharmaceuticals, Inc.
Jan 31, 2026
Exercise(M)
Direct
54.9K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jan 31, 2026
Tax Payment(F)
Direct
16.1K shares at avg. $4.24$68K
AVIR
Atea Pharmaceuticals, Inc.
Jan 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
180K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jan 31, 2025
Tax Payment(F)
Direct
16.1K shares at avg. $3.06$49K
AVIR
Atea Pharmaceuticals, Inc.
Jan 31, 2025
Exercise(M)
Direct
44.4K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jan 31, 2025
Award(A)
Direct
10.5K shares-

		Type	Shares	Price		Ownership
Mar 11, 2026	AVIR Atea Pharmaceuticals, Inc.	Exercise(M)	60,000	$1.24	$74,400	Direct
Jan 31, 2026	AVIR Atea Pharmaceuticals, Inc.	Exercise(M)	54,866	-	$0	Direct
Jan 31, 2026	AVIR Atea Pharmaceuticals, Inc.	Tax Payment(F)	16,104	$4.24	$68,281	Direct
Jan 31, 2026	AVIR Atea Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	180,000	-	-	Direct
Jan 31, 2025	AVIR Atea Pharmaceuticals, Inc.	Tax Payment(F)	16,102	$3.06	$49,272	Direct
Jan 31, 2025	AVIR Atea Pharmaceuticals, Inc.	Exercise(M)	44,367	-	-	Direct
Jan 31, 2025	AVIR Atea Pharmaceuticals, Inc.	Award(A)	10,500	-	-	Direct

1-7 of 7 transactions

About Corcoran Andrea

Corcoran Andrea (SEC CIK 0001296996) files insider reports with the SEC as Officer of Atea Pharmaceuticals, Inc. (AVIR).

Signal8 holds 3 ownership filings by Corcoran Andrea, all Form 4s, filed between Feb 4, 2025 and Mar 13, 2026. Those filings report 7 transactions, from Jan 31, 2025 to Mar 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Corcoran Andrea's filings is in BOSTON, MA.

Recent filings by Corcoran Andrea

Mar 11, 2026: Option exercise of AVIR shares (Form 4, code M).
Jan 31, 2026: Option exercise of AVIR shares (Form 4, code M).
Jan 31, 2026: Tax withholding of AVIR shares (Form 4, code F).
Jan 31, 2026: Grant or award of AVIR derivative securities (Form 4, code A).
Jan 31, 2025: Tax withholding of AVIR shares (Form 4, code F).

Other insiders filing for Atea Pharmaceuticals, Inc. (AVIR)

Lucidi Bruno, Director
BERGER FRANKLIN M, Director
Berman Howard, Director
DUNCAN BARBARA GAYLE, Director
Polsky Bruce, Director
Murphy Polly A., Director

How to read Form 4 transaction codes